HT
ABUS icon

HAP Trading’s Arbutus Biopharma ABUS Stock Holding History

HAP Trading’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,600
Closed -$28K – 1701
2022
Q2 		$28K Sell
20,600
-48,500
-70% -$124K ﹤0.01% 1239
2022
Q1 		$46K Sell
69,100
-35,800
-34% -$110K ﹤0.01% 1288
2021
Q4 		$64K Buy
104,900
+78,700
+300% +$306K ﹤0.01% 1370
2021
Q3 		$9K Sell
26,200
-8,500
-24% -$28.3K ﹤0.01% 2030
2021
Q2 		$7K Buy
+34,700
New +$107K ﹤0.01% 2065
2021
Q1 		– Sell
-21,600
Closed -$29K – 1867
2020
Q4 		$29K Buy
+21,600
New +$75.6K ﹤0.01% 1591

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return